AIMS: To test the efficacy of two smoking cessation interventions in a HIV positive (HIV+) sample: standard care (SC) treatment plus nicotine replacement therapy (NRT) versus more intensive motivationally enhanced (ME) treatment plus NRT. DESIGN: Randomized controlled trial. SETTING:HIV+ smoker referrals from eight immunology clinics in the northeastern United States. PARTICIPANTS: A total of 444 participants enrolled in the study (mean age = 42.07 years; 63.28% male; 51.80% European American; mean cigarettes/day = 18.27). INTERVENTIONS: SC participants received two brief sessions with a health educator. Those setting a quit date received self-help quitting materials and NRT. ME participants received four sessions of motivational counseling and a quit-day counseling call. All ME intervention materials were tailored to the needs of HIV+ individuals. MEASUREMENTS: Biochemically verified 7-day abstinence rates at 2-month, 4-month and 6-month follow-ups. FINDINGS:Intent-to-treat (ITT) abstinence rates at 2-month, 4-month and 6-month follow-ups were 12%, 9% and 9%, respectively, in the ME condition, and 13%, 10% and 10%, respectively, in the SC condition, indicating no between-group differences. Among 412 participants with treatment utilization data, 6-month ITT abstinence rates were associated positively with low nicotine dependence (P = 0.02), high motivation to quit (P = 0.04) and Hispanic American race/ethnicity (P = 0.02). Adjusting for these variables, each additional NRT contact improved the odds of smoking abstinence by a third (odds ratio = 1.32, 95% confidence interval = 0.99-1.75). CONCLUSIONS: Motivationally enhanced treatment plus NRT did not improve cessation rates over and above standard care treatment plus NRT in this HIV+ sample of smokers. Providers offering brief support and encouraging use of nicotine replacement may be able to help HIV+ patients to quit smoking.
RCT Entities:
AIMS: To test the efficacy of two smoking cessation interventions in a HIV positive (HIV+) sample: standard care (SC) treatment plus nicotine replacement therapy (NRT) versus more intensive motivationally enhanced (ME) treatment plus NRT. DESIGN: Randomized controlled trial. SETTING: HIV+ smoker referrals from eight immunology clinics in the northeastern United States. PARTICIPANTS: A total of 444 participants enrolled in the study (mean age = 42.07 years; 63.28% male; 51.80% European American; mean cigarettes/day = 18.27). INTERVENTIONS: SC participants received two brief sessions with a health educator. Those setting a quit date received self-help quitting materials and NRT. MEparticipants received four sessions of motivational counseling and a quit-day counseling call. All ME intervention materials were tailored to the needs of HIV+ individuals. MEASUREMENTS: Biochemically verified 7-day abstinence rates at 2-month, 4-month and 6-month follow-ups. FINDINGS: Intent-to-treat (ITT) abstinence rates at 2-month, 4-month and 6-month follow-ups were 12%, 9% and 9%, respectively, in the ME condition, and 13%, 10% and 10%, respectively, in the SC condition, indicating no between-group differences. Among 412 participants with treatment utilization data, 6-month ITT abstinence rates were associated positively with low nicotine dependence (P = 0.02), high motivation to quit (P = 0.04) and Hispanic American race/ethnicity (P = 0.02). Adjusting for these variables, each additional NRT contact improved the odds of smoking abstinence by a third (odds ratio = 1.32, 95% confidence interval = 0.99-1.75). CONCLUSIONS: Motivationally enhanced treatment plus NRT did not improve cessation rates over and above standard care treatment plus NRT in this HIV+ sample of smokers. Providers offering brief support and encouraging use of nicotine replacement may be able to help HIV+ patients to quit smoking.
Authors: Rakhi Kohli; Yungtai Lo; Peter Homel; Timothy P Flanigan; Lytt I Gardner; Andrea A Howard; Anne M Rompalo; Galina Moskaleva; Paula Schuman; Ellie E Schoenbaum Journal: Clin Infect Dis Date: 2006-05-25 Impact factor: 9.079
Authors: Patricia Daza; Ludmila Cofta-Woerpel; Carlos Mazas; Rachel T Fouladi; Paul M Cinciripini; Ellen R Gritz; David W Wetter Journal: Subst Use Misuse Date: 2006 Impact factor: 2.164
Authors: Kolawole S Okuyemi; Aimee S James; Matthew S Mayo; Nicole Nollen; Delwyn Catley; Won S Choi; Jasjit S Ahluwalia Journal: Health Educ Behav Date: 2006-06-15
Authors: Jasjit S Ahluwalia; Kolawole Okuyemi; Nicole Nollen; Won S Choi; Harsohena Kaur; Kim Pulvers; Matthew S Mayo Journal: Addiction Date: 2006-06 Impact factor: 6.526
Authors: Eric A Engels; Malcolm V Brock; Jinbo Chen; Craig M Hooker; Maura Gillison; Richard D Moore Journal: J Clin Oncol Date: 2006-03-20 Impact factor: 44.544
Authors: Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read Journal: Am J Public Health Date: 2010-08-19 Impact factor: 9.308
Authors: Jonathan Shuter; Alyson B Moadel; Ryung S Kim; Andrea H Weinberger; Cassandra A Stanton Journal: Nicotine Tob Res Date: 2014-08-23 Impact factor: 4.244
Authors: Robert A Schnoll; Morgan Thompson; Katrina Serrano; Frank Leone; David Metzger; Ian Frank; Robert Gross; Karam Mounzer; Rachel F Tyndale; Jessica Weisbrot; Miles Meline; Ronald G Collman; Rebecca L Ashare Journal: J Acquir Immune Defic Syndr Date: 2019-02-01 Impact factor: 3.731
Authors: D R Bailey Miles; Usama Bilal; Heidi E Hutton; Bryan Lau; Catherine R Lesko; Anthony Fojo; Mary E McCaul; Jeanne Keruly; Richard D Moore; Geetanjali Chander Journal: J Health Care Poor Underserved Date: 2019
Authors: Karen L Cropsey; James H Willig; Michael J Mugavero; Heidi M Crane; Cheryl McCullumsmith; Sarah Lawrence; James L Raper; W Christopher Mathews; Stephen Boswell; Mari M Kitahata; Joseph E Schumacher; Michael S Saag Journal: J Addict Med Date: 2016 Jan-Feb Impact factor: 3.702
Authors: Conall O'Cleirigh; Sarah E Valentine; Megan Pinkston; Debra Herman; C Andres Bedoya; Janna R Gordon; Steven A Safren Journal: AIDS Behav Date: 2015-01
Authors: Patricia A Cioe; Kristi E Gamarel; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler Journal: AIDS Care Date: 2016-10-02